Intellectual Property India Publishes Patent Application for 'Isolated Antigen-Binding Protein And Use Thereof' Filed by Guangzhou Lintonpharm Co. Ltd.

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517032619 A) filed by Guangzhou Lintonpharm Co. Ltd., Guangdong, China, on April 2, for 'isolated antigen-binding protein and use thereof.'

Inventor(s) include Horst Lindhofer; Sun, Zhe; and Li, Dongchen.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to an isolated antigen-binding protein, which comprises a CD3-binding moiety, wherein the CD3-binding moiety comprises amino acid sequences having at least 95% identity to heavy chain variable regions HCDR1, HCDR2 and HCDR3; the amino acid sequence of the HCDR1 i...